Grifols SA (GRFS)
7.85
-0.01
(-0.13%)
USD |
NASDAQ |
Jan 07, 16:00
7.87
+0.02
(+0.25%)
After-Hours: 20:00
Grifols Shareholders Equity (Quarterly): 5.975B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Trinity Biotech PLC | -26.34M |
| Akari Therapeutics PLC | -6.694M |
| TC BioPharm (Holdings) PLC | 2.535M |
| Cellectis SA | 129.42M |
| Evaxion Biotech AS | 0.074M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.65B |
| Total Liabilities (Quarterly) | 13.73B |
| Current Ratio | 2.260 |
| Net Debt Paydown Yield | 31.04% |